In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile-Reference-Cited by-同舟云学术

In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile

Published:2020-04 Issue: Volume:872 Page:172947
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Kuo Andy,Magiera Julia,Rethwan Nursyazwani,Andersson Åsa,Leen Lam Ai,Wyse Bruce,Meutermans Wim,Lewis Richard,Smith Maree

Funder

Australian Research Council

Queensland Government

Publisher

Elsevier BV

Subject

Pharmacology

Reference51 articles.

1. Mapping signaling pathway cross-talk in Drosophila cells;Ammeux;Proc. Natl. Acad. Sci. U. S. A.,2016

2. Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis;Atwood;BMC Genom.,2011

3. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells;Bot;Mol. Pharmacol.,1997

4. 3H-morphine-6beta-glucuronide binding in brain membranes and an MOR-1-transfected cell line;Brown;J. Pharmacol. Exp. Therapeut.,1997

5. Cyclic AMP compartments and signaling specificity: role of cyclic nucleotide phosphodiesterases;Conti;J. Gen. Physiol.,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Safety of Oliceridine Fumarate Injection in Chinese Patients with Chronic Non-Cancer Pain: A Phase I, Single-Ascending-Dose, Open-Label Clinical Trial;Drug Design, Development and Therapy;2024-07

2. Clarifying intrinsic efficacy, partial agonism, and full agonism: moving beyond efficacy and affinity towards ligand-directed signalling. Comment on Br J Anaesth 2024; 132: 431–2;British Journal of Anaesthesia;2024-06

3. seco-1-Azacubane-2-carboxylic Acid: Derivative Scope and Comparative Biological Evaluation;The Journal of Organic Chemistry;2023-12-22

4. An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine;Pharmaceuticals;2023-10-02

5. CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats;Pharmacological Reports;2023-01-13